Abbott eyes $20B bond sale to fund purchase of Exact Sciences - report
Source: SeekingAlpha
2026-02-23 11:10:57 ET
More on Abbott Laboratories, Exact Sciences
- Abbott: Long-Term Investment Opportunity For Dividend Growth Investors
- Abbott Laboratories: Double-Digit Earnings Growth Makes It A Buy
- Abbott Laboratories: The Market's Overreaction Is The Long-Term Investor's Opportunity
- Exact Sciences shareholders approve acquisition by Abbott
- Insider trades: Merck, Intel, Micron among notable names
Read the full article on Seeking Alpha
For further details see:
Abbott eyes $20B bond sale to fund purchase of Exact Sciences - report
Exact Sciences Corporation
NASDAQ: EXAS
EXAS Trading
-0.07% G/L:
$103.37 Last:
833,436 Volume:
$103.35 Open:
EXAS Latest News
March 04, 2026 09:00:00 am
Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year
March 03, 2026 10:00:00 am
Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration
February 25, 2026 09:40:00 am
Forget Tilray: This Steady Income Stock Beats Wild Cannabis Swings Every Time
EXAS Stock Data
$19,584,719,665
187,197,642
0.09%
291
N/A
Medical Diagnostics & Screening
Healthcare
US
Madison
